Do you want to remove "electric slickline equipment" from your favorites?
Remove Now
Cancle
Guaifensin and Dextromethorphan Hydrobromide Tablets
FOB Reference Price / Min.Order Quantity
: Get Latest Prices
Processing Time:1 Days - 60 Days
Packaging Details:
STANDARD EXPORTING PACKAGE
Port: Shanghai / Shenzhen / Qingdao / Ningbo / Other
Payment Terms: L/C , T/T , other
Product Information:
1. Product name: Dextromethorphan hydrobromide
2. Specification: 99%
3. Appearance: white or white-like crystal powder
4. CAS No.: 125-69-9
5. Molecular formula: C18H25NO.HBr.H2O
Package details: 25kg/drum with two plastic-bags inside or as your requirement
Usage:
The primary use of dextromethorphen hydrobromide is as an antitussive, or cough suppressant. This is one of the most popular ingredients in over-the-counter cold and cough medications. This medication may be added to other preparations to help treat pain and a variety of other disturbances as well; Dry cough
Dextromethorphen Hydrobromide Anhydrous is also available.
|
Product name
|
Dextromethorphan hydrobromide
|
|
Batch No.
|
KNCA0116
|
Sample quantity
|
50.00 gm
|
|
A.R.NO
|
10000421898
|
Date of analysis
|
03.12.2009
|
|
Manufacture date
|
DEC.2009
|
Expiry date
|
NOV.2014
|
|
Ref. standard
|
USP32
|
Packing
|
50g/bag
|
TEST
|
RESULT
|
SPECIFICATION
|
|
Description
|
White crystalline powder
|
Practically white crystals or crystalline powder having a faint odour.
|
|
Solubility
|
Complies
|
Sparingly soluble in water, freely soluble in alcohol and in chloroform and insoluble in ether.
|
|
Identification by
a. IR
|
Complies
|
The infrared absorption spectrum of finely ground sample in potassium bromide dispersion compressed into a pellet, exhibits maxima only at the same wave lengths as that of a similar preparation of the corresponding Dextromethorphan HBr WS
|
|
b. UV absorption
|
1.58%
|
Absorbtivity at 278nm of sample (100μg/ml(on anhydrous basis)solution in 0.1N hydrochloric acid) do not differ from a similar preparation of Dextromethorphan Hydrobromide WS by more than 3.0%
|
|
c. With silver Nitrate TS
|
Complies
|
A yellowish wihte precipitate formed when 5 drops of 2N nitric acid and 2ml of silver nitrate TS are added to 5ml of sample solution.
|
|
Melting point
|
126.5°C with decomposition
|
Melts at about 126°C with decomposition.
|
|
Specific optical rotation at 25°
|
0.30%
|
The specific rotation of the sample at 325nm do (on anhydrous basis) not differ from a similar preparation of (C=1,8 in water) Dextromethorphan hydrobromic WS, by more than 1.0%
|
|
Ph (1 in 100)
|
6.38
|
Between 5.20 and 6.50
|
|
Water by KF
|
4.45% w/w
|
Between 3.5and 5.5% w/w
|
|
Residue on ignition
|
0.04% than 0.001%
|
Not more than 0.1% w/w
|
|
Limit of N,N-dimethylaniline
|
Less than 0.001%
|
Not more than 0.001%
|
|
Limit of phenolic compounds
|
Complies
|
No blue-green colour develops
|
|
Assay (on anhydrous basis)
|
99.58% w/w
|
Not less than 98.0% and
Not less than 102.0% w/w
|
Merro Pharmaceutical Co., Ltd.
Basic Information
Business Type:
Main Products:
Location:
Total Employees:
Year Established:
Trade Information
Top 3 Markets:
Accepted Payment Currency:
Nearest Port:
Average Lead Time:
Overseas Office: No
Company Pictures
Verified Supplier
Credit Check